WITH THE CORONAVIRUS OUTBREAK
With the coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760…
With the coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760…
The industry associations — Indian Drug Manufacturers’ Association (IDMA), Organisation of Pharmaceutical Producers of India (OPPI), Pharmaceuticals Export Promotion Council of India (Pharmexcil), among others have given an undertaking…
Ipca Laboratories, for instance, was supposed to deliver 5 lakh blisters of hydroxychloroquine (HCQS) tablets to the Central government by last Tuesday, but it had delivered the tablets after…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat…
Donec ornare ornare lacinia. Praesent ullamcorper pretium elit in sodales. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nam nec lorem nec nibh volutpat…
Recent Comments